Max Hubmann

530 total citations
13 papers, 271 citations indexed

About

Max Hubmann is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Max Hubmann has authored 13 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 4 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Max Hubmann's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Polyomavirus and related diseases (3 papers). Max Hubmann is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Polyomavirus and related diseases (3 papers). Max Hubmann collaborates with scholars based in Germany, France and New Zealand. Max Hubmann's co-authors include Thomas Köhnke, Dušan Prevalšek, Roland Hardt, Christoph Schulz, Veit Bücklein, Johanna Tischer, Max Schaldach, Andreas Hausmann, Susanne Fritsch and Hans‐Joachim Stemmler and has published in prestigious journals such as Blood, Leukemia and American Journal of Hematology.

In The Last Decade

Max Hubmann

12 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Hubmann Germany 8 193 53 52 45 41 13 271
Erin H. Breese United States 10 109 0.6× 83 1.6× 117 2.3× 20 0.4× 16 0.4× 26 297
Maria Vittoria Gazzola Italy 9 175 0.9× 33 0.6× 63 1.2× 16 0.4× 10 0.2× 13 332
Marc Müller Germany 9 96 0.5× 48 0.9× 69 1.3× 13 0.3× 9 0.2× 18 254
Xiebing Bao China 10 119 0.6× 89 1.7× 53 1.0× 44 1.0× 19 0.5× 35 219
A Kolialexi Greece 12 39 0.2× 16 0.3× 119 2.3× 32 0.7× 35 0.9× 25 305
Ahmad Rayes United States 6 98 0.5× 98 1.8× 96 1.8× 19 0.4× 8 0.2× 11 271
Loïc Delens Belgium 8 179 0.9× 69 1.3× 58 1.1× 18 0.4× 7 0.2× 12 301
E. Ösby Sweden 9 57 0.3× 57 1.1× 72 1.4× 23 0.5× 4 0.1× 20 272
S Neu Germany 5 249 1.3× 106 2.0× 55 1.1× 27 0.6× 4 0.1× 9 386
Klaus Rehe Germany 7 95 0.5× 45 0.8× 61 1.2× 20 0.4× 15 0.4× 11 239

Countries citing papers authored by Max Hubmann

Since Specialization
Citations

This map shows the geographic impact of Max Hubmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Hubmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Hubmann more than expected).

Fields of papers citing papers by Max Hubmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Hubmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Hubmann. The network helps show where Max Hubmann may publish in the future.

Co-authorship network of co-authors of Max Hubmann

This figure shows the co-authorship network connecting the top 25 collaborators of Max Hubmann. A scholar is included among the top collaborators of Max Hubmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Hubmann. Max Hubmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gaballa, Mahmoud, Nobuhiro Tsukada, Kazuhito Suzuki, et al.. (2024). Real-World Experience with Isatuximab in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Iona-MM Second Interim Analysis. Blood. 144(Supplement 1). 2411.5–2411.5. 1 indexed citations
2.
Fraccaroli, Alessia, Dušan Prevalšek, Veit Bücklein, et al.. (2019). Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning—a matched pair analysis. Annals of Hematology. 98(3). 753–762. 7 indexed citations
3.
Rothenberg‐Thurley, Maja, Susanne Amler, Dennis Göerlich, et al.. (2018). Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia. Leukemia. 32(7). 1598–1608. 106 indexed citations
4.
Fraccaroli, Alessia, Dušan Prevalšek, Susanne Fritsch, et al.. (2018). Sequential HLA‐haploidentical transplantation utilizing post‐transplantation cyclophosphamide for GvHD prophylaxis in high‐risk and relapsed/refractory AML/MDS. American Journal of Hematology. 93(12). 1524–1531. 16 indexed citations
5.
Hubmann, Max, Susanne Fritsch, Dušan Prevalšek, et al.. (2016). Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation. Journal of Clinical Virology. 82. 33–40. 21 indexed citations
6.
Tischer, Johanna, Nicole Engel, Susanne Fritsch, et al.. (2015). Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings. Annals of Hematology. 94(10). 1677–1688. 54 indexed citations
7.
8.
Dietzfelbinger, Hermann & Max Hubmann. (2015). Hämolytische Anämien und Vitamin-B12-Mangel. DMW - Deutsche Medizinische Wochenschrift. 140(17). 1302–1312. 1 indexed citations
9.
Reibke, Roland, Andrea Dick, Max Hubmann, et al.. (2014). Monitoring of Bone Marrow Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation – Evaluation of a qPCR Based Chimerism Assay. Blood. 124(21). 3866–3866. 1 indexed citations
10.
Tischer, Johanna, Hans‐Joachim Stemmler, Nicole Engel, et al.. (2013). Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia. Annals of Hematology. 92(10). 1379–1388. 24 indexed citations
11.
12.
Schaldach, Max, et al.. (1990). Sputter‐Deposited TiN Electrode Coatings for Superior Sensing and Pacing Performance. Pacing and Clinical Electrophysiology. 13(12). 1891–1895. 30 indexed citations
13.
Hubmann, Max, et al.. (1982). A survey of contrast media used in coronary angiography. CardioVascular and Interventional Radiology. 5(3-4). 202–210. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erin H. Breese Breakdown of academic impact, for papers by Maria Vittoria Gazzola Breakdown of academic impact, for papers by Marc Müller Breakdown of academic impact, for papers by Xiebing Bao Breakdown of academic impact, for papers by A Kolialexi Breakdown of academic impact, for papers by Ahmad Rayes Breakdown of academic impact, for papers by Loïc Delens Breakdown of academic impact, for papers by E. Ösby Breakdown of academic impact, for papers by S Neu Breakdown of academic impact, for papers by Klaus Rehe
Rankless by CCL
2026